Philadelphia Pharmaceuticals Company (ASE:PHIL)

Jordan flag Jordan · Delayed Price · Currency is JOD
1.550
0.00 (0.00%)
At close: Feb 25, 2026
0.00%
Market Cap 11.63M
Revenue (ttm) 9.11M
Net Income (ttm) 913.26K
Shares Out 7.50M
EPS (ttm) 0.12
PE Ratio 12.73
Forward PE n/a
Dividend 0.07 (4.52%)
Ex-Dividend Date Feb 26, 2025
Volume 30
Average Volume 300
Open 1.550
Previous Close n/a
Day's Range 1.550 - 1.550
52-Week Range 1.360 - 1.700
Beta -0.04
RSI 51.92
Earnings Date Feb 9, 2026

About ASE:PHIL

Philadelphia Pharmaceuticals Company develops, manufactures, and markets human pharmaceutical products, cosmetics, and medical devices of various therapeutic categories in Jordan. The company provides products for skin related disorders, including anti-lice and scabicides preparations, antiseptics and disinfectants, bleaching and hyperpigmentation disorders preparations, emollients and protectives, keratolytics/topical psoriasis treatment preparations, and skin healing agents, as well as agents for dermatitis; and topical acne preparation, anti... [Read more]

Industry Pharmaceutical Preparations
Founded 1993
Employees 129
Stock Exchange Amman Stock Exchange
Ticker Symbol PHIL
Full Company Profile

Financial Performance

In 2024, ASE:PHIL's revenue was 8.76 million, an increase of 4.25% compared to the previous year's 8.40 million. Earnings were 821,518, an increase of 1.77%.

Financial Statements

News

There is no news available yet.